Literature DB >> 29401032

HIV Prevention Drug's Slow Uptake Undercuts Its Early Promise.

David Tuller1.   

Abstract

Initially billed as a game changer, Truvada has faced multiple obstacles to widespread adoption.

Entities:  

Keywords:  AIDS/HIV; Disparities; Public Health

Mesh：

Substances：

Year:  2018        PMID： 29401032     DOI： 10.1377/hlthaff.2017.1650

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN： 0278-2715            Impact factor:   6.301


  4 in total

1.  Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.

Authors:  Patrick S Sullivan; Robertino Mera Giler; Farah Mouhanna; Elizabeth S Pembleton; Jodie L Guest; Jeb Jones; Amanda D Castel; Howa Yeung; Michael Kramer; Scott McCallister; Aaron J Siegler
Journal:  Ann Epidemiol       Date:  2018-06-22       Impact factor: 3.797

2.  Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015-2016.

Authors:  Stephanie S Chan; Andre R Chappel; Karen E Joynt Maddox; Karen W Hoover; Ya-Lin A Huang; Weiming Zhu; Stacy M Cohen; Pamela W Klein; Nancy De Lew
Journal:  PLoS Med       Date:  2020-04-10       Impact factor: 11.069

3.  Assessing the Role of Gay Community Attachment, Stigma, and PrEP Stereotypes on Young Men Who Have Sex with Men's PrEP Uptake.

Authors:  Steven Meanley; Daniel Connochie; Seul Ki Choi; Stephen Bonett; Dalmacio D Flores; José A Bauermeister
Journal:  AIDS Behav       Date:  2020-11-19

4.  Segmented intravaginal ring for the combination delivery of hydroxychloroquine and anti-CCR5 siRNA nanoparticles as a potential strategy for preventing HIV infection.

Authors:  Yannick L Traore; Yufei Chen; Fernanda Padilla; Emmanuel A Ho
Journal:  Drug Deliv Transl Res       Date:  2021-04-17       Impact factor: 4.617
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.